• LAST PRICE
    0.3000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.3000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    ---
    High 0.3000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesWPHM
Winston Pharmaceuticals Inc
23.2M
-8.2x
---
United StatesCLRB
Cellectar Biosciences Inc
22.9M
-0.9x
---
United StatesAGRI
AgriFORCE Growing Systems Ltd
22.7M
-1.9x
---
United StatesBWV
Blue Water Vaccines Inc
24.5M
-1.9x
---
United StatesONPH
Oncology Pharma Inc
24.3M
0.0x
---
United StatesPYPD
PolyPid Ltd
20.7M
-0.4x
---
As of 2022-09-25

Company Information

Winston Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company discovers, develops and commercializes therapeutics for managing and alleviating pain. The Company's late stage candidates include products for the treatment of episodic cluster headache, chronic migraine headache, osteoarthritis, rheumatoid arthritis, neuropathic pain, and pain and inflammation in inflammatory bowel disease. The Company is developing Civamide, which is a transient receptor potential channels vanilloid-1 (TRPV-1) modulator in different dosage forms for several different pain indications. The Company's other products are under development for the treatment of headache and neuropathic and rheumatological pain.

Contact Information

Headquarters
100 N Fairway Dr Ste 134VERNON HILLS, IL, United States 60061-1859
Phone
847-362-8200
Fax
847-362-8394

Executives

Chairman of the Board
Robert Yolles
President, Chief Executive Officer, Director
Joel Bernstein
President, Chief Executive Officer
Jeffrey Bernstein
Chief Financial Officer, Vice President, Secretary
David Starr
Senior Vice President - Scientific Affairs, Director
Scott Phillips

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$23.2M
Revenue (TTM)
$1.4M
Shares Outstanding
77.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.04
Book Value
$0.01
P/E Ratio
-8.2x
Price/Sales (TTM)
16.9
Price/Cash Flow (TTM)
---
Operating Margin
-176.09%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.